Xpert® MRSA/SA Blood Culture
Détection précise de SARM et de S. aureus à partir d’échantillons d’hémoculture positifs en une heure environ
Pour afficher les prix, connectez-vous ou créez un compte MyCepheid.
Taille du coffret test
image de produit
10 tests
GXMRSA/SA-BC-10
Qté
Prix unitaire
Sous-total
USD
Le produit n’est pas disponible à l’achat dans votre région.
Total
{{currency}}
0
Erreur lors de l’ajout d’articles au panier. Si cette erreur persiste, veuillez communiquer avec le soutien numérique.

Questions fréquemment posées

The Xpert® MRSA/SA Blood Culture test, performed on the GeneXpert® systems, is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA directly from positive blood cultures.1 

The test utilizes automated real-time polymerase chain reaction (PCR) for the amplification of MRSA/SA specific DNA targets and fluorogenic target-specific hybridization probes for the real-time detection of the amplified DNA.1 

The Xpert MRSA/SA Blood Culture test is indicated for use in conjunction with other laboratory tests, such as culture, and clinical data available to the clinician as an aid in the detection of MRSA/SA from positive blood cultures. Subculturing of positive blood cultures is necessary to recover organisms for susceptibility testing or for epidemiological typing. The Cepheid Xpert MRSA/SA Blood Culture test is not intended to monitor treatment for MRSA/SA infections.1

Staphylococcus aureus (SA) is a human pathogen, which is the causative agent of a range of diseases including bacteremia, endocarditis, osteomyelitis, toxic shock syndrome, food poisoning, carbuncles, and boils.1

In the early 1950s, acquisition and spread of beta-lactamase-producing plasmids thwarted the effectiveness of penicillin for treating SA infections. In 1959, methicillin, a semi-synthetic penicillin, was introduced and, soon after, methicillin-resistant SA (MRSA) strains were identified.1

MRSA colonization increases the risk of infection, with infecting strains match colonizing strains in as many as 50–80% of cases. MRSA nasal colonization rates range from 0.9% to 1.5% in the United States2

Références :

 

1. Xpert® MRSA/SA Blood Culture Package Insert. Consulté le 9/25/2024. https://www.cepheid.com/fr-CAntent/dam/www-cepheid-com/documents/package-insert-files/301-1061-mrsa-sa-bc/IFU%20MRSA.SA%20BC%20ENGLISH%20301-1061%20Rev%20F.pdf


2. Turner, N.A., Sharma-Kuinkel, B.K., Maskarinec, S.A. et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17, 203–218 (2019). https://doi.org/10:1038/s41579-018-0147-4

Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web